Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.
Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.
News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.
Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.
Dentsply Sirona, the largest manufacturer of professional dental products, announced an investor conference call on May 3, 2023, at 8:30 am ET. This call will discuss the company’s first quarter financial results. The live webcast can be accessed via the Investors section of their website. Registrants can secure their participation through this link, and a replay will be made available afterward.
Dentsply Sirona has a long-standing history of innovation in the dental industry and continues to provide high-quality solutions for patient care. Their products are marketed under various world-class brands, enhancing dental and oral health worldwide.
Dentsply Sirona (Nasdaq: XRAY) announced a $150 million accelerated share repurchase (ASR) agreement with Goldman Sachs, aimed at enhancing shareholder value. Under this agreement, the company will initially acquire around 3.1 million shares. The final share count will be determined based on the stock's average price during the ASR's valuation period, with potential adjustments affecting total expenditure. The completion of this ASR is expected by the end of Q2 2023, reflecting Dentsply Sirona's commitment to returning capital to shareholders and optimizing its capital structure.
DENTSPLY SIRONA reported a challenging FY22 with net sales decreasing by 7.3% to $3,922 million, compared to $4,231 million in FY21. The company experienced a net loss of $950 million or ($4.41) per share, significantly down from a net income of $411 million in FY21. Q4 showed a 10.9% drop in net sales to $983 million, with adjusted EPS falling 44.4% to $0.46. For FY23, the outlook suggests net sales between $3.85 billion and $3.95 billion, with adjusted EPS anticipated in the range of $1.80 to $2.00.
Dentsply Sirona (Nasdaq: XRAY) announced a major organizational restructuring plan aimed at boosting operational efficiency and shareholder value. The plan is expected to yield between $200 million and $225 million in annual cost savings over the next 18 months. Key components include an 8%-10% workforce reduction, establishment of five global business units, and an optimized management structure. Additionally, the company anticipates $165 million in non-recurring charges, mainly in 2023, while aiming for adjusted earnings of $3.00 per share by 2026. The restructuring aligns with Dentsply Sirona's strategy to address a challenging external environment while fostering sustainable growth.
Dentsply Sirona, a leading manufacturer of dental products, will host an investor conference call and live webcast on February 28, 2023, at 8:30 am ET. This event aims to discuss the company’s fourth quarter and full year 2022 financial results. Interested participants can find the presentation and register for the call on Dentsply Sirona's Investor Relations website at https://investor.dentsplysirona.com. A replay of the webcast will also be accessible afterward. Dentsply Sirona is headquartered in Charlotte, North Carolina, and is known for its innovative dental technologies.
Dentsply Sirona (Nasdaq: XRAY) presented at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023. The company forecasts net sales exceeding $3.88 billion, surpassing its previous outlook range of $3.85 billion to $3.88 billion. The adjusted EPS for the full year 2022 is anticipated to remain within the prior guidance of $1.90 to $2.00. Presentation materials and webcast details are accessible on the company's investor website.
DENTSPLY SIRONA (Nasdaq: XRAY) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 10:30 am PT (1:30 pm ET). A live audio webcast of the presentation will be accessible via the company's investors section on their website. Dentsply Sirona, headquartered in Charlotte, North Carolina, is the world's largest manufacturer of professional dental products, providing innovative solutions that enhance patient care and safety.
Dentsply Sirona (Nasdaq: XRAY) has declared a quarterly cash dividend of $0.125 per share, translating to an indicated annual rate of $0.50 per share. The dividend will be payable on January 13, 2023, to shareholders on record as of December 30, 2022. This move reflects the company’s commitment to returning value to its shareholders while continuing its longstanding history in the dental industry.
Dentsply Sirona reported third-quarter 2022 net sales of $947 million, down by 8.9% year-over-year, with a GAAP loss of $5.01 per share. Adjusted EPS fell by 31.5% to $0.41. Key factors included foreign currency impacts and macroeconomic headwinds, with organic sales slightly declining by 0.7%. The company initiated a comprehensive review to enhance execution and return to growth. Full-year guidance reflects an expected organic sales decline of approximately 2% and adjusted EPS projected between $1.90 and $2.00.
Dentsply Sirona (Nasdaq: XRAY) announced its participation in two key upcoming healthcare conferences. The first is the Jefferies 13th Annual London Healthcare Conference scheduled for November 17, 2022, at 12:20 pm GMT (7:20 am ET). The second is the Evercore ISI 5th Annual HealthCONx Conference on December 1, 2022, at 1:00 pm ET. Interested investors can access live webcasts of these presentations via the Dentsply Sirona website. As the world's largest manufacturer of dental products, Dentsply Sirona focuses on innovative solutions for patient care.